Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus
- 31 May 1996
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 54 (1), 123-128
- https://doi.org/10.1016/0091-3057(95)02108-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of researchPharmacology & Therapeutics, 1995
- Contrasting behavioural effects of 8-OH DPAT in the dorsal raphénucleus and ventral hippocampusNeuropharmacology, 1994
- The interplay of learning and anxiety in the elevated plus-mazeBehavioural Brain Research, 1993
- Multiple serotonin mechanisms in animal models of anxiety: Environmental, emotional and cognitive factorsBehavioural Brain Research, 1993
- Molecular Basis of Buspirone's Anxiolytic ActionBasic & Clinical Pharmacology & Toxicology, 1991
- The discovery and development of buspirone: A new approach to the treatment of anxietyMedicinal Research Reviews, 1990
- Novel antihypertensive drug reveals unexpected complexities in β-adrenoceptor pharmacologyTrends in Pharmacological Sciences, 1989
- Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the ratNeuropharmacology, 1988
- Can animal tests of anxiety detect panic‐promoting agents?Human Psychopharmacology: Clinical and Experimental, 1988
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987